EPBIO.BO EP Biocomposites Ltd BSE +9.89% pre-market 24 Jan 2026: monitor breakout
EPBIO.BO stock jumped 9.89% in pre-market trade to INR 98.90 on BSE on 24 Jan 2026, up from the previous close of INR 90.00. The move makes EP Biocomposites Ltd. one of today’s top gainers in the Industrials sector, though the advance comes on light volume of 500.00 shares versus an average of 2,328.00. We look at valuation, technicals, Meyka AI grading and a short-term outlook to help traders and investors weigh momentum against fundamentals.
Pre-market move: EPBIO.BO stock performance
EPBIO.BO stock opened and traded at INR 98.90 in pre-market, marking a +9.89% one-day rise from INR 90.00. The day range was tight at INR 98.90 – INR 98.90, with reported volume of 500.00 shares, below the 50-day average volume of 2,328.00. This suggests a short, sharp move rather than broad-based buying.
Valuation and fundamentals for EPBIO.BO stock
EP Biocomposites Ltd (EPBIO.BO) trades at PE 18.15 with EPS INR 5.45 and market cap INR 166,371,558.00. Price-to-book is 1.57 and price-to-sales is 1.68, both modest versus large-cap peers. The company reports book value per share INR 63.11 and a current ratio of 3.95, indicating strong short-term liquidity.
Receivables are elevated; days sales outstanding sits at 404.18 days which is a structural cash conversion concern. Debt-to-equity is moderate at 0.28, and return on equity is 8.99%, showing profitable operations but limited scale.
Technicals and intraday signals for EPBIO.BO stock
Short-term momentum is mixed: RSI is 47.80 (neutral) and MACD histogram is slightly positive at 1.67, supporting the pre-market lift. Bollinger bands range shows upper INR 114.85 and lower INR 87.06, placing the current price near the band middle.
Key technical levels: support near the year low INR 90.00 and band lower INR 87.06; resistance around INR 100.00 then INR 114.85. Low relative volume warns that follow-through is uncertain.
Meyka AI rates EPBIO.BO with a score out of 100 and forecast
Meyka AI rates EPBIO.BO with a score of 63.88 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational only and not financial advice.
Meyka AI’s forecast model projects a 12-month target of INR 73.71, a quarterly target of INR 48.45, and a monthly projection of INR 38.57. Compared with the current price INR 98.90, the 12-month projection implies an approximate -25.47% downside. Forecasts are model-based projections and not guarantees. For quick reference visit the company site EP Biocomposites website or BSE main page BSE.
Catalysts, sector context and risks for EPBIO.BO stock
Positive catalysts: niche product demand for fibre-reinforced polymers, contracts in construction and WASH (bio-toilets), and margin improvement could support upside. Industrial – Machinery sector trends remain weak year-to-date, with the broader Industrials sector down -7.48% YTD, so sector headwinds matter.
Risks: small free float and low liquidity (shares outstanding 1,682,220.00) can amplify volatility. High days sales outstanding (404.18) raises credit and collection risk. Lack of imminent earnings announcements adds uncertainty.
Trading strategy and short-term outlook for EPBIO.BO stock
For short-term traders: treat the pre-market gain as a momentum setup but trade size should be small given thin volumes. Consider intraday entries above INR 100.00 with stop-loss near INR 90.00 to limit downside. Use target zones at INR 114.85 (Bollinger upper) and INR 120.00 for a nimble exit.
For longer-term investors: rely on fundamental improvement—lower receivables and higher asset turnover—before adding positions. Use Meyka AI-powered market analysis platform outputs as one input among fundamental checks.
Final Thoughts
EPBIO.BO stock is the leading pre-market gainer on BSE on 24 Jan 2026, advancing +9.89% to INR 98.90 on light volume. The rally highlights momentum but is tempered by thin liquidity, elevated receivables (days sales outstanding 404.18), and a modest market cap INR 166,371,558.00. Valuation metrics like PE 18.15 and PB 1.57 do not appear stretched, yet Meyka AI’s 12-month model projects INR 73.71, implying roughly -25.47% downside versus the current price. Traders can exploit breakout levels near INR 100.00 with tight risk controls. Investors should wait for clearer improvements in cash conversion and volume before increasing exposure. Remember, forecasts and grades are model-driven and not guarantees
FAQs
Why did EPBIO.BO stock jump in pre-market trade today?
The pre-market jump to INR 98.90 (+9.89%) came on a short burst of buying with light volume (500.00). Moves like this often reflect newsflow, dealer activity, or position adjustments in a low-liquidity stock rather than broad market demand.
What are the key valuation metrics for EPBIO.BO stock?
EP Biocomposites trades at PE 18.15, PB 1.57, and price-to-sales 1.68. Return on equity is 8.99% and current ratio 3.95, suggesting adequate liquidity but modest profitability relative to larger peers.
How should traders approach EPBIO.BO stock in the short term?
Short-term traders can watch a confirmed break above INR 100.00 with volume. Use a stop near INR 90.00 and targets at INR 114.85 and INR 120.00. Keep position sizes small due to low average volume.
What does the Meyka AI forecast say about EPBIO.BO stock?
Meyka AI’s model projects a 12-month target of INR 73.71, a quarterly target of INR 48.45, and a monthly figure INR 38.57. The 12-month projection implies roughly -25.47% from current price; model outputs are projections, not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
